Locomotor hyperactivity following prenatal exposure to 5-bromo-2'-deoxyuridine: neurochemical and behavioral evidence of dopaminergic and serotonergic alterations.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Toxicology Letters

• Publication date

  2004-08-30

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.TOXLET.2004.03.019PMID 15294348
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects ofd-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment

  2004cited by this paper
• Disruption of brain development in male rats exposed prenatally to 5‐bromo‐2‘‐deoxyuridine

  2001cited by this paper
• Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats.

  2001cited by this paper
• Non-selective attention in a rat model of hyperactivity and attention deficit: subchronic methylphenydate and nitric oxide synthesis inhibitor treatment.

  2000cited by this paper
• Methylphenidate affects striatal dopamine differently in an animal model for attention-deficit/hyperactivity disorder--the spontaneously hypertensive rat.

  2000cited by this paper
• The Distribution of Serotonergic Nerves in Microencephalic Rats Treated Prenatally with Methylazoxymethanol

  2000cited by this paper
• The nucleus accumbens motor-limbic interface of the spontaneously hypertensive rat as studied in vitro by the superfusion slice technique.

  2000cited by this paper
• The duration of the effects of a single administration of dopamine antagonists on ambulatory activity and motor coordination

  1999cited by this paper
• Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.

  1999cited by this paper
• Embryonic and Postnatal Injections of Bromodeoxyuridine Produce Age-Dependent Morphological and Behavioral Abnormalities

  1999cited by this paper
• Prenatal administration of nicotine results in dopaminergic alterations in the neocortex.

  1999cited by this paper
• Diversity and attention deficit hyperactivity disorder.

  1998cited by this paper
• Profound neuronal plasticity in response to inactivation of the dopamine transporter.

  1998cited by this paper
• Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis.

  1998cited by this paper
• Clinical foundations of hyperactivity research.

  1998cited by this paper
• Behavior and reproductive function of rat male offspring treated prenatally with 5-bromo-2'-deoxyuridine.

  1998cited by this paper
• Attention deficit/hyperactivity disorder--from brain dysfunctions to behaviour.

  1998cited by this paper
• Differences between electrically-, ritalin- and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of Attention-Deficit Hyperactivity Disorder.

  1998cited by this paper
• Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

  1996cited by this paper
• Reproductive effects of prenatal exposure to 5-bromo-2'-deoxyuridine on male rats.

  1996cited by this paper
• Potentiating effects of methamphetamine on the hyperactivity of microencephalic rats treated prenatally with methylazoxymethanol: possible implication of hyperdopaminergia.

  1995cited by this paper
• Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.

  1995cited by this paper
• Decreased dominance in a limited access test but normal maternal behavior in micrencephalic rats.

  1995cited by this paper
• Proposed animal model of attention deficit hyperactivity disorder.

  1994cited by this paper
• Genetic and neurobiological aspects of attention deficit hyperactive disorder: a review.

  1994cited by this paper
• Ultrastructural analysis of the serotonin hyperinnervation in adult rat neostriatum following neonatal dopamine denervation with 6-hydroxydopamine.

  1992cited by this paper
• Ketamine-induced anesthesia involves the N-methyl-D-aspartate receptor-channel complex in mice.

  1992cited by this paper
• The genetic toxicology of 5-bromodeoxyuridine in mammalian cells.

  1991cited by this paper
• Behavioural effects of serotonin agonists and antagonists in the rat and marmoset.

  1990cited by this paper
• Antagonism of 8-OH-DPAT-induced behaviour in rats.

  1990cited by this paper
• Serotonergic innervation of the rat caudate following a neonatal 6-hydroxydopamine lesion: an anatomical, biochemical and pharmacological study.

  1989cited by this paper
• The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo.

  1988cited by this paper
• Component analyses differentiate between exploratory behaviour of spontaneously hypertensive rats and Wistar Kyoto rats in a two-compartment free-exploration open field.

  1988cited by this paper
• The 5-HT1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo

  1988cited by this paper
• Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta.

  1987cited by this paper
• Anomalous neural differentiation induced by 5-bromo-2'-deoxyuridine during organogenesis in the rat.

  1987cited by this paper
• Modulation of In Vivo Dopamine Release by D2 but Not D1 Receptor Agonists and Antagonists

  1987cited by this paper
• Heterogeneity of neurons in the subnucleus interpolaris of the cat.

  1984cited by this paper
• Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of striatal drug infusions.

  1984cited by this paper
• Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.

  1982cited by this paper
• Effects of prenatal methylazoxymethanol treatment on the development of central monoamine neurons.

  1981cited by this paper
• Teratological evaluation of 5-fluorouracil and 5-bromo-2-deoxyuridine on hamster fetuses.

  1978cited by this paper
• The effect of 5-bromodeoxyuridine on the postnatal development of the rat cerebellum: morphologic and radioautographic studies.

  1977cited by this paper
• The effect of 5-bromodeoxyuridine on the postnatal development of the rat cerebellum: morphologic and radioautographic studies.

  1977cited by this paper
• The effect of 5-bromodeoxyuridine on the postnatal development of the rat cerebellum: a biochemical study.

  1976cited by this paper
• Distribution of 5-bromodeoxyuridine in the DNA of rat embryo cells.

  1974cited by this paper
• Effect of fluorodeoxyuridine, colcemid, and bromodeoxyuridine on developing neocortex of the mouse.

  1973cited by this paper
• The teratogenic response of mouse embryos to 5-bromodeoxyuridine.

  1971cited by this paper
• REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I

  1966cited by this paper
• The embryocidal and teratogenic effects of 5-bromodeoxyuridine in the pregnant hamster.

  1965cited by this paper
• The embryocidal and teratogenic effects of 5-bromodeoxyuridine in the pregnant hamster.

  1965cited by this paper
• Development of a strain of spontaneously hypertensive rats.

  1963cited by this paper

• The number and distribution of proliferating cells in the rat’s rostral migratory stream as identified by means of two different proliferation markers

  2024cites this paper
• Hypothalamic Monoaminergic Pathology in a Neurodevelopmental Rat Model Showing Prenatal 5-Bromo-2′-Deoxyuridine Treatment-Induced Hyperactivity and Hyporeproductivity

  2019cites this paper
• BrdU-induced hyperlocomotion in the stroked rat.

  2019cites this paper
• Sex Differences in Psychiatric Disease: A Focus on the Glutamate System

  2018cites this paper
• Does serotonin deficit mediate susceptibility to ADHD?

  2015cites this paper
• Developmental Neurotoxicology: History and Outline of Developmental Neurotoxicity Study Guidelines

  2015cites this paper
• Expanding the test set: Chemicals with potential to disrupt mammalian brain development.

  2015cites this paper
• Mother/Offspring Co-administration of the Traditional Herbal Remedy Yokukansan During the Nursing Period Influences Grooming and Cerebellar Serotonin Levels in a Rat Model of Neurodevelopmental Disorders

  2014cites this paper
• Sexual Dimorphism in Monoamine Metabolism in BrdU-Treated Rats Showing Behavioral Dopamine Hypersensitivity: An Animal Model of Schizophrenia

  2013cites this paper
• Developmental neurotoxicity testing: Scientific approaches towards the next generation to protect the developing nervous system of children. An overview of the Developmental Neurotoxicity Symposium in 2011

  2012cites this paper
• Abnormal brain function of the rat neonate in a prenatal 5‐bromo‐2′‐deoxyuridine (BrdU)‐induced developmental disorder model

  2012cites this paper
• Current problems of in vivo developmental neurotoxicity tests and a new in vivo approach focusing on each step of the developing central nervous system

  2012cites this paper
• Hyperactivity induced by prenatal BrdU exposure across several experimental conditions

  2011cites this paper
• Effects of the genotoxic agent 5-bromo-2'-deoxyuridine with or without pre-pubertal gonadectomy on brain monoamines and their metabolites in female rats.

  2011cites this paper
• Does 5-bromo-2'-deoxyuridine (BrdU) disrupt cell proliferation and neuronal maturation in the adult rat hippocampus in vivo?

  2009cites this paper
• Characteristic behavioral anomalies in rats prenatally exposed to 5‐bromo‐2′‐deoxyuridine

  2009cites this paper
• Everything that glitters isn't gold: a critical review of postnatal neural precursor analyses.

  2007cites this paper
• The evaluation of early embryonic neurogenesis after exposure to the genotoxic agent 5-bromo-2'-deoxyuridine in mice.

  2007cites this paper
• Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.

  2007cites this paper
• Neurogenesis is Toxicologically Heterogeneous: A Case of BrdU-lnduced Cell Death

  2006cites this paper
• Dopamine transporter density and behavioral response to methylphenidate in a hyperlocomotor rat model

  2006cites this paper
• Neuropathological examination of fetal rat brain in the 5‐bromo‐2′‐deoxyuridine‐induced neurodevelopmental disorder model

  2005cites this paper